Cargando…
Fluoroquinolone resistance in bacteremic and low risk febrile neutropenic patients with cancer
BACKGROUND: The low risk febrile neutropenic patients with Multinational Association for Supportive Care in Cancer (MASCC) score of more than 20 are recommended to be treated with fluoroquinolone-based oral treatment by the National Comprehensive Cancer Network (NCCN) guideline. This recommendation...
Autores principales: | Zhang, Sheng, Wang, Qing, Ling, Yun, Hu, Xichun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326398/ https://www.ncbi.nlm.nih.gov/pubmed/25763661 http://dx.doi.org/10.1186/s12885-015-1063-x |
Ejemplares similares
-
Food-borne bacteremic illnesses in febrile neutropenic children
por: Lee, Anselm Chi-wai, et al.
Publicado: (2011) -
Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: A descriptive study
por: Irfan, Seema, et al.
Publicado: (2008) -
Classification of Chemotherapy-Induced Febrile Neutropenic Episodes Into One of the Three Febrile Neutropenic Syndromes
por: Raheja, Ronak, et al.
Publicado: (2023) -
460 Bacteremic vs Non-bacteremic Febrile Episodes in Children with Cancer: Prospective Multicenter Study in 5 Centers in Israel
por: Averbuch, Diana, et al.
Publicado: (2014) -
Antibiotic-Resistant Gram-Negative Bacteremia in Febrile Neutropenic Children
por: Lee, Jina
Publicado: (2016)